HEADER HYDROLASE 09-FEB-09 3G6Z TITLE DESIGN AND PREPARATION OF POTENT, NON-PEPTIDIC, BIOAVAILABLE RENIN TITLE 2 INHIBITORS CAVEAT 3G6Z NAG A 344 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HUMAN EMBRYONIC KIDNEY CELL KEYWDS RENIN HUMAN, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, KEYWDS 2 DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, PROTEASE, KEYWDS 3 SECRETED, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR O.BEZENCON,D.BUR,L.PRADE,T.WELLER,C.BOSS,W.FISCHLI REVDAT 3 29-JUL-20 3G6Z 1 CAVEAT COMPND REMARK SEQADV REVDAT 3 2 1 HET HETNAM FORMUL LINK REVDAT 3 3 1 SITE ATOM REVDAT 2 13-JUL-11 3G6Z 1 VERSN REVDAT 1 30-JUN-09 3G6Z 0 JRNL AUTH O.BEZENCON,D.BUR,T.WELLER,S.RICHARD-BILDSTEIN,L.REMEN, JRNL AUTH 2 T.SIFFERLEN,O.CORMINBOEUF,C.GRISOSTOMI,C.BOSS,L.PRADE, JRNL AUTH 3 S.DELAHAYE,A.TREIBER,P.STRICKNER,C.BINKERT,P.HESS,B.STEINER, JRNL AUTH 4 W.FISCHLI JRNL TITL DESIGN AND PREPARATION OF POTENT, NONPEPTIDIC, BIOAVAILABLE JRNL TITL 2 RENIN INHIBITORS JRNL REF J.MED.CHEM. V. 52 3689 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19358611 JRNL DOI 10.1021/JM900022F REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 3 NUMBER OF REFLECTIONS : 45661 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2455 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2377 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.33 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 131 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5175 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 435 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.44000 REMARK 3 B22 (A**2) : 1.89000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.207 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.192 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.518 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5466 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7431 ; 1.474 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 671 ; 7.035 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;34.870 ;23.964 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 859 ;18.233 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;20.824 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 826 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4116 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2212 ; 0.215 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3666 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 342 ; 0.155 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.197 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.224 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3405 ; 0.944 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5373 ; 1.556 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2371 ; 2.100 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2052 ; 3.265 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3G6Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1000051501. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52656 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 70.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.6 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.75150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.91600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.37550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.91600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.75150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.37550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 167 REMARK 465 ASN A 168 REMARK 465 SER A 169 REMARK 465 GLN A 170 REMARK 465 LEU B 1 REMARK 465 THR B 2 REMARK 465 LEU B 3 REMARK 465 GLU B 167 REMARK 465 ASN B 168 REMARK 465 SER B 169 REMARK 465 GLN B 170 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 421 O HOH B 525 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL B 104 CB - CA - C ANGL. DEV. = -15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 29.20 -142.06 REMARK 500 ARG A 53 2.01 -61.28 REMARK 500 ASN A 75 -69.84 -126.56 REMARK 500 THR A 214 98.47 -63.51 REMARK 500 ARG A 251 -122.38 -84.76 REMARK 500 LEU A 252 -61.89 -91.37 REMARK 500 SER B 8 135.85 -170.37 REMARK 500 ASN B 75 -70.40 -131.33 REMARK 500 LYS B 250 48.57 -82.90 REMARK 500 LEU B 252 -140.99 47.45 REMARK 500 ALA B 299 33.98 -82.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D91 RELATED DB: PDB REMARK 900 RELATED ID: 3G70 RELATED DB: PDB REMARK 900 RELATED ID: 3G72 RELATED DB: PDB DBREF 3G6Z A 1 340 UNP P00797 RENI_HUMAN 67 406 DBREF 3G6Z B 1 340 UNP P00797 RENI_HUMAN 67 406 SEQADV 3G6Z HIS A 341 UNP P00797 EXPRESSION TAG SEQADV 3G6Z HIS B 341 UNP P00797 EXPRESSION TAG SEQRES 1 A 341 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 341 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 341 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 341 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 341 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 341 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 341 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 341 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 341 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 341 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 341 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 341 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 341 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 341 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 341 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 341 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 341 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 341 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 341 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 341 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 341 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 341 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 341 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 341 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 341 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 341 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 341 ALA ARG HIS SEQRES 1 B 341 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 B 341 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 B 341 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 B 341 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 B 341 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 B 341 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 B 341 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 B 341 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 B 341 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 B 341 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 B 341 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 B 341 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 B 341 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 B 341 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 B 341 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 B 341 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 B 341 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 B 341 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 B 341 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 B 341 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 B 341 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 B 341 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 B 341 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 B 341 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 B 341 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 B 341 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 B 341 ALA ARG HIS MODRES 3G6Z ASN A 5 ASN GLYCOSYLATION SITE MODRES 3G6Z ASN A 75 ASN GLYCOSYLATION SITE MODRES 3G6Z ASN B 75 ASN GLYCOSYLATION SITE HET A7T A 342 43 HET NAG A 343 14 HET NAG A 344 14 HET A7T B 342 43 HET NAG B 343 14 HETNAM A7T (1R,5S)-N-CYCLOPROPYL-7-{4-[2-(2,6-DICHLORO-4- HETNAM 2 A7T METHYLPHENOXY)ETHOXY]PHENYL}-N-(2,3-DIMETHYLBENZYL)-3, HETNAM 3 A7T 9-DIAZABICYCLO[3.3.1]NON-6-ENE-6-CARBOXAMIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 3 A7T 2(C35 H39 CL2 N3 O3) FORMUL 4 NAG 3(C8 H15 N O6) FORMUL 8 HOH *435(H2 O) HELIX 1 1 TYR A 55 TYR A 60 1 6 HELIX 2 2 ASP A 65 SER A 69 5 5 HELIX 3 3 PRO A 118 ALA A 122 5 5 HELIX 4 4 PHE A 132 VAL A 140 5 9 HELIX 5 5 PRO A 142 GLN A 150 1 9 HELIX 6 6 ASP A 182 GLN A 184 5 3 HELIX 7 7 SER A 235 ALA A 245 1 11 HELIX 8 8 GLU A 261 LEU A 265 5 5 HELIX 9 9 THR A 280 VAL A 285 1 6 HELIX 10 10 GLY A 316 LYS A 322 1 7 HELIX 11 11 TYR B 55 TYR B 60 1 6 HELIX 12 12 ASP B 65 SER B 69 5 5 HELIX 13 13 PRO B 118 ALA B 122 5 5 HELIX 14 14 PHE B 132 VAL B 140 5 9 HELIX 15 15 PRO B 142 SER B 149 1 8 HELIX 16 16 ASP B 182 GLN B 184 5 3 HELIX 17 17 SER B 235 GLY B 247 1 13 HELIX 18 18 ASN B 260 LEU B 265 5 6 HELIX 19 19 THR B 280 VAL B 285 1 6 HELIX 20 20 GLY B 316 LYS B 322 1 7 SHEET 1 A 9 LYS A 73 TYR A 83 0 SHEET 2 A 9 GLY A 86 VAL A 99 -1 O GLY A 90 N LEU A 79 SHEET 3 A 9 GLN A 19 ILE A 26 -1 N GLY A 25 O THR A 98 SHEET 4 A 9 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 5 A 9 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 6 A 9 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177 SHEET 7 A 9 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 8 A 9 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 9 A 9 TYR A 186 ASN A 194 -1 N GLU A 187 O LEU A 338 SHEET 1 B13 LYS A 73 TYR A 83 0 SHEET 2 B13 GLY A 86 VAL A 99 -1 O GLY A 90 N LEU A 79 SHEET 3 B13 ILE A 102 GLU A 113 -1 O VAL A 104 N ILE A 97 SHEET 4 B13 VAL A 44 PRO A 47 1 N VAL A 44 O GLY A 109 SHEET 5 B13 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45 SHEET 6 B13 GLN A 31 ASP A 38 1 N VAL A 36 O VAL A 128 SHEET 7 B13 GLN A 19 ILE A 26 -1 N GLY A 22 O VAL A 35 SHEET 8 B13 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 9 B13 GLY A 174 LEU A 178 -1 O LEU A 178 N SER A 8 SHEET 10 B13 VAL A 157 TYR A 162 -1 N SER A 159 O VAL A 177 SHEET 11 B13 PHE A 323 ASP A 328 -1 O PHE A 327 N PHE A 158 SHEET 12 B13 ARG A 333 ALA A 339 -1 O GLY A 335 N GLU A 326 SHEET 13 B13 TYR A 186 ASN A 194 -1 N GLU A 187 O LEU A 338 SHEET 1 C 5 GLN A 202 MET A 205 0 SHEET 2 C 5 CYS A 221 VAL A 225 -1 O CYS A 221 N MET A 205 SHEET 3 C 5 TRP A 313 LEU A 315 1 O LEU A 315 N LEU A 224 SHEET 4 C 5 ILE A 232 GLY A 234 -1 N SER A 233 O ALA A 314 SHEET 5 C 5 ILE A 300 ALA A 302 1 O HIS A 301 N ILE A 232 SHEET 1 D 4 SER A 213 LEU A 216 0 SHEET 2 D 4 VAL A 208 VAL A 210 -1 N VAL A 208 O LEU A 216 SHEET 3 D 4 ILE A 268 HIS A 271 -1 O SER A 269 N SER A 209 SHEET 4 D 4 GLU A 276 LEU A 279 -1 O TYR A 277 N PHE A 270 SHEET 1 E 3 LYS A 249 LYS A 250 0 SHEET 2 E 3 TYR A 255 LYS A 258 -1 O VAL A 256 N LYS A 249 SHEET 3 E 3 LEU A 295 THR A 297 -1 O CYS A 296 N VAL A 257 SHEET 1 F 9 LYS B 73 TYR B 83 0 SHEET 2 F 9 GLY B 86 VAL B 99 -1 O LEU B 92 N GLY B 76 SHEET 3 F 9 GLN B 19 ILE B 26 -1 N GLY B 25 O THR B 98 SHEET 4 F 9 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 5 F 9 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 6 F 9 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 7 F 9 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 8 F 9 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 9 F 9 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336 SHEET 1 G13 LYS B 73 TYR B 83 0 SHEET 2 G13 GLY B 86 VAL B 99 -1 O LEU B 92 N GLY B 76 SHEET 3 G13 ILE B 102 GLU B 113 -1 O VAL B 104 N ILE B 97 SHEET 4 G13 VAL B 44 PRO B 47 1 N VAL B 46 O VAL B 111 SHEET 5 G13 GLY B 126 GLY B 129 -1 O VAL B 127 N TRP B 45 SHEET 6 G13 GLN B 31 ASP B 38 1 N VAL B 36 O VAL B 128 SHEET 7 G13 GLN B 19 ILE B 26 -1 N GLY B 22 O VAL B 35 SHEET 8 G13 SER B 8 TYR B 15 -1 N TYR B 15 O GLN B 19 SHEET 9 G13 GLY B 174 LEU B 178 -1 O LEU B 178 N SER B 8 SHEET 10 G13 VAL B 157 TYR B 162 -1 N TYR B 161 O GLN B 175 SHEET 11 G13 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE B 158 SHEET 12 G13 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 13 G13 TYR B 186 ASN B 194 -1 N HIS B 191 O PHE B 336 SHEET 1 H 5 GLN B 202 MET B 205 0 SHEET 2 H 5 CYS B 221 VAL B 225 -1 O CYS B 221 N MET B 205 SHEET 3 H 5 TRP B 313 LEU B 315 1 O LEU B 315 N LEU B 224 SHEET 4 H 5 ILE B 232 GLY B 234 -1 N SER B 233 O ALA B 314 SHEET 5 H 5 ILE B 300 ALA B 302 1 O HIS B 301 N ILE B 232 SHEET 1 I 4 SER B 213 LEU B 216 0 SHEET 2 I 4 GLY B 207 VAL B 210 -1 N VAL B 208 O LEU B 216 SHEET 3 I 4 ILE B 268 LEU B 272 -1 O SER B 269 N SER B 209 SHEET 4 I 4 LYS B 275 LEU B 279 -1 O LEU B 279 N ILE B 268 SHEET 1 J 2 VAL B 256 LYS B 258 0 SHEET 2 J 2 LEU B 295 THR B 297 -1 O CYS B 296 N VAL B 257 SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.05 SSBOND 2 CYS A 217 CYS A 221 1555 1555 2.03 SSBOND 3 CYS A 259 CYS A 296 1555 1555 2.07 SSBOND 4 CYS B 51 CYS B 58 1555 1555 1.98 SSBOND 5 CYS B 217 CYS B 221 1555 1555 2.07 SSBOND 6 CYS B 259 CYS B 296 1555 1555 2.07 LINK ND2 ASN A 5 C1 NAG A 343 1555 1555 1.45 LINK ND2 ASN A 75 C1 NAG A 344 1555 1555 1.45 LINK ND2 ASN B 75 C1 NAG B 343 1555 1555 1.45 CISPEP 1 THR A 28 PRO A 29 0 4.52 CISPEP 2 LEU A 117 PRO A 118 0 1.68 CISPEP 3 PRO A 307 PRO A 308 0 4.64 CISPEP 4 GLY A 310 PRO A 311 0 0.81 CISPEP 5 THR B 28 PRO B 29 0 -2.86 CISPEP 6 LEU B 117 PRO B 118 0 -0.98 CISPEP 7 PRO B 307 PRO B 308 0 2.30 CISPEP 8 GLY B 310 PRO B 311 0 -14.63 CRYST1 67.503 94.751 119.832 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014814 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010554 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008345 0.00000